4911

G&E Herbal Biotechnology Stock Price

Symbol: TPEX:4911Market Cap: NT$3.1bCategory: Household

4911 Share Price Performance

Community Fair Values

    Recent 4911 News & Updates

    No updates

    G&E Herbal Biotechnology Co., Ltd. Key Details

    NT$273.8m

    Revenue

    NT$45.7m

    Cost of Revenue

    NT$228.1m

    Gross Profit

    NT$109.2m

    Other Expenses

    NT$119.0m

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    1.87
    Gross Margin
    83.32%
    Net Profit Margin
    43.45%
    Debt/Equity Ratio
    0%

    G&E Herbal Biotechnology Co., Ltd. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About 4911

    Founded
    2002
    Employees
    39
    CEO
    Kou-Wha Kou
    WebsiteView website
    www.geherbs.com.tw

    G&E Herbal Biotechnology Co., Ltd. engages in development and commercialization of novel botanical extraction technology and products. It offers Hepanamin capsules; botoniocal healthcare products; botanical anti-aging cosmetics, which includes facial cleansing essence, botonic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; and adult products, including lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.

    Taiwanese Market Performance

    • 7 Days: 0.3%
    • 3 Months: 12.3%
    • 1 Year: 6.6%
    • Year to Date: 2.0%
    The Energy sector gained 7.6% while the market remained flat over the last week. As for the longer term, the market has risen 6.6% in the past 12 months. Looking forward, earnings are forecast to grow by 13% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading